During the past decade, St. Louis Cancer Care conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 23 clinical trials were completed, i.e. on average, 209.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Louis Cancer Care" #1 sponsor was "SCRI Development Innovations, LLC" with 20 trials, followed by "Celgene" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Dendreon" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Louis Cancer Care" #1 collaborator was "Bristol-Myers Squibb" with 6 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Bayer" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "St. Louis Cancer Care" are "Breast Cancer" (6 trials), "Metastatic Breast Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Small Cell Lung Cancer" (3 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "St. Louis Cancer Care" in a lesser frequency.

Most popular intervention types in "St. Louis Cancer Care" are "Drug" (34 trials), "Biological" (4 trials), "Other" (3 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (8 trials), "Placebo" (6 trials), "Bevacizumab" (5 trials), "Cyclophosphamide" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Louis Cancer Care" are 35 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St. Louis Cancer Care". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in St. Louis Cancer Care, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in St. Louis Cancer Care, 5 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".